Diabetes other than T2DM; receiving insulin, growth hormone, glucocorticoids, or anabolic steroids; eGFR < 30 mL/min/1.73 m2; proliferative retinopathy; contraindication to exercise due to bone and joint disease; current treatment for malignancy. This evidence concerns the gene INS and retinal disorder.